athenahealth Receives Consensus Recommendation of “Buy” from Brokerages (NASDAQ:ATHN)
athenahealth (NASDAQ:ATHN) has been given an average recommendation of “Buy” by the twenty-four analysts that are presently covering the stock, StockRatingsNetwork reports. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and thirteen have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $165.10.
ATHN has been the subject of a number of recent research reports. Analysts at Barclays reiterated an “equal weight” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $128.00 price target on the stock, up previously from $125.00. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $170.00 price target on the stock, down previously from $185.00. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of athenahealth in a research note on Monday, July 21st. They now have a $180.00 price target on the stock, down previously from $200.00.
In other athenahealth news, CMO Robert Cosinuke sold 6,000 shares of the company’s stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $129.43, for a total value of $776,580.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
athenahealth (NASDAQ:ATHN) opened at 131.03 on Tuesday. athenahealth has a 1-year low of $97.30 and a 1-year high of $206.70. The stock has a 50-day moving average of $127.8 and a 200-day moving average of $143.4. The company has a market cap of $4.974 billion and a P/E ratio of 1204.13.
athenahealth (NASDAQ:ATHN) last released its earnings data on Thursday, July 17th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.10. The company had revenue of $185.90 million for the quarter, compared to the consensus estimate of $182.14 million. During the same quarter in the prior year, the company posted ($0.08) earnings per share. The company’s quarterly revenue was up 27.1% on a year-over-year basis. On average, analysts predict that athenahealth will post $1.09 earnings per share for the current fiscal year.
athenahealth, Inc (NASDAQ:ATHN), is a business services company, which provides ongoing billing, clinical-related, and other related services to its customers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.